• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA25-90/I16-30
Device Problems Misconnection (1399); Unintended Movement (3026)
Patient Problems Failure of Implant (1924); No Code Available (3191)
Event Date 03/27/2019
Event Type  Injury  
Manufacturer Narrative
Endologix will continue to investigate the reported event.The patient medical records and imaging studies have been requested for further evaluation by a clinical specialist.A final report will be submitted once the investigation of the reported event has concluded.
 
Event Description
An afx2 bifurcated stent graft and an afx vela suprarenal were implanted to treat an abdominal aortic aneurysm (aaa).Approximately two (2) years post op, a routine follow-up ct identified component separation.The patient is being monitored.
 
Manufacturer Narrative
At the completion of the clinical evaluation and based on the information received, there was substantial evidence to support the reported type iiia endoleak between the bifurcated and suprarenal extension devices with a secondary endovascular procedure.The event is most likely anatomy-related due to the aortic remodeling observed on 24-month computed tomography (ct) images and compared with the pre-ct.Procedure-related harms for this event could not be determined.The final patient status was reported as being stable.The manufacturing lot review confirmed all devices met specifications prior to release.These types of events will be monitored and trended as part of the quality system.Device iteration is afx2.
 
Event Description
Additional information received confirming that the physician elected to treat the patient by implanting an infrarenal and additional suprarenal afx devices on (b)(6) 2019.The patient is reportedly doing well and the component separation was resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key8546633
MDR Text Key142968749
Report Number2031527-2019-00212
Device Sequence Number1
Product Code MIH
UDI-Public(01)0081800901486317)171109
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Recall
Type of Report Initial,Followup
Report Date 03/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/24/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/09/2017
Device Model NumberBEA25-90/I16-30
Device Lot Number1613714010
Was Device Available for Evaluation? No
Date Manufacturer Received03/27/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-0007-2019
Patient Sequence Number1
Treatment
AFX VELA SUPRARENAL (LN 1624701010); AFX VELA SUPRARENAL (LN 1624701010)
Patient Outcome(s) Other; Required Intervention;
Patient Age81 YR
-
-